Year |
Citation |
Score |
2021 |
Li R, Salehi-Rad R, Crosson W, Momcilovic M, Lim RJ, Ong SL, Huang ZL, Zhang T, Abascal J, Dumitras C, Jing Z, Park SJ, Krysan K, Shackelford DB, Tran LM, et al. Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-deficient Non-Small Cell Lung Cancer. Cancer Research. PMID 33853830 DOI: 10.1158/0008-5472.CAN-20-3564 |
0.345 |
|
2021 |
Salehi-Rad R, Li R, Tran LM, Lim RJ, Abascal J, Momcilovic M, Park SJ, Ong SL, Shabihkhani M, Huang ZL, Paul M, Shackelford DB, Krysan K, Liu B, Dubinett SM. Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden. Cancer Immunology, Immunotherapy : Cii. PMID 33507343 DOI: 10.1007/s00262-020-02837-9 |
0.309 |
|
2020 |
Li R, Ong SL, Tran LM, Jing Z, Liu B, Park SJ, Huang ZL, Walser TC, Heinrich EL, Lee G, Salehi-Rad R, Crosson WP, Pagano PC, Paul MK, Xu S, et al. Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Scientific Reports. 10: 4386. PMID 32127587 DOI: 10.1038/S41598-020-61341-3 |
0.335 |
|
2020 |
Salehi-Rad R, Li R, Paul MK, Dubinett SM, Liu B. The Biology of Lung Cancer: Development of More Effective Methods for Prevention, Diagnosis, and Treatment. Clinics in Chest Medicine. 41: 25-38. PMID 32008627 DOI: 10.1016/J.Ccm.2019.10.003 |
0.396 |
|
2020 |
Li R, Ong SL, Tran LM, Jing Z, Liu B, Park SJ, Huang ZL, Walser TC, Heinrich EL, Lee G, Salehi-Rad R, Crosson WP, Pagano PC, Paul MK, Xu S, et al. Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Scientific Reports. 10: 377. PMID 31941995 DOI: 10.1038/S41598-019-57285-Y |
0.372 |
|
2020 |
Li R, Salehi-Rad R, Momcilovic M, Ong S, Lim R, Huang ZL, Tran L, Jing Z, Paul M, Teitell M, Minna J, Shackelford D, Kostyantyn K, Liu B, Dubinett S. Abstract 1016: Inhibition of chemokine-induced myeloid cells potentiates the anti-PD-1 response in KRAS/LKB1 mutant non-small cell lung cancer Immunology. DOI: 10.1158/1538-7445.Am2020-1016 |
0.409 |
|
2020 |
Salehi-Rad R, Li R, Lim R, Tran L, Abascal J, Ong S, Liu B, Dubinett S. A35 Dendritic Cell in Situ Vaccination Potentiates Anti-PD-1 Efficacy and Induces Immunoediting in a Murine Model of NSCLC Journal of Thoracic Oncology. 15: S24. DOI: 10.1016/J.Jtho.2019.12.064 |
0.321 |
|
2020 |
Li R, Salehi-Rad R, Momcilovic M, Lim R, Ong S, Huang Z, Tran L, Zhe J, Paul M, Teitell M, Minna J, Krysan K, Shackelford D, Liu B, Dubinett S. A11 Blockade of Myeloid Suppressor Cells Overcomes the Anti-PD-1/PD-L1 Resistance in KRAS-Driven and LKB1-Deficient NSCLC Journal of Thoracic Oncology. 15: S15. DOI: 10.1016/J.Jtho.2019.12.040 |
0.307 |
|
2019 |
Krysan K, Tran LM, Grimes BS, Fishbein GA, Seki A, Gardner BK, Walser TC, Salehi-Rad R, Yanagawa J, Lee JM, Sharma S, Aberle D, Spira AE, Elashoff DA, Wallace WD, et al. The immune contexture associates with the genomic landscape in lung adenomatous premalignancy. Cancer Research. PMID 31142513 DOI: 10.1158/0008-5472.Can-19-0153 |
0.349 |
|
2019 |
Salehi-Rad R, Dubinett SM. Understanding the mechanisms of immune-evasion by lung cancer in the context of chronic inflammation in emphysema. Journal of Thoracic Disease. 11: 382-385. PMID 30962980 DOI: 10.21037/Jtd.2019.01.22 |
0.354 |
|
2019 |
Liu B, Garon EB, Lisberg AE, Salehi-Rad R, Lee JM, Tran LM, Krysan K, Li R, Lim RJ, Paul M, Lin Y, Jing Z, Abtin F, Suh RD, Oh S, et al. Abstract CT226: A Phase I trial ofin situvaccination with autologousCCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct226 |
0.364 |
|
2019 |
Li R, Salehi-Rad R, Ong S, Momcilovic M, Liu B, Lim R, Tran L, Huang Z, Jing Z, Paul M, Krysan K, Park S, Minna J, Teitell M, Shackelford D, et al. Abstract 2710: Depletion of CXCR2-dependent myeloid-derived suppressor cells (MDSCs) overcomes anti-PD-1 resistance in a murine model of LKB1-deficient non-small cell lung cancer (NSCLC) with high mutational load Cancer Research. 79: 2710-2710. DOI: 10.1158/1538-7445.Am2019-2710 |
0.419 |
|
2018 |
Chattopadhyay A, Yang X, Mukherjee P, Sulaiman D, Fogelman HR, Grijalva V, Dubinett S, Wasler TC, Paul MK, Salehi-Rad R, Mack JJ, Iruela-Arispe ML, Navab M, Fogelman AM, Reddy ST. Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer. Scientific Reports. 8: 9032. PMID 29899427 DOI: 10.1038/S41598-018-26755-0 |
0.361 |
|
2018 |
Salehi-Rad R, Dubinett SM. Understanding the Hurdles in Lung Cancer Immunotherapy in the Context of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. PMID 29589957 DOI: 10.1164/Rccm.201803-0523Ed |
0.34 |
|
2017 |
Lee JMM, Lee MH, Garon E, Goldman JW, Salehi-Rad R, Baratelli FE, Schaue D, Wang G, Rosen F, Yanagawa J, Walser TC, Lin Y, Park SJ, Adams S, Marincola FM, et al. Phase I trial of intratumoral injection of CCL21 gene modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8+ T cell infiltration. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28468947 DOI: 10.1158/1078-0432.Ccr-16-2821 |
0.358 |
|
2017 |
Salehi-Rad R, Walser T, Ong S, Park S, Sharma S, Jay L, Dubinett S. CCL21 Combined with PD-1 Blockade Cooperatively Inhibits Tumor Growth in KRAS Murine Model of NSCLC Journal of Thoracic Oncology. 12: S1537. DOI: 10.1016/J.Jtho.2017.06.026 |
0.327 |
|
2016 |
Salehi-rad R, Walser TC, Yakobian N, Park SJ, Lee M, Lee JM, Sharma S, Dubinett SM. Intratumoral CCL21 and checkpoint blockade cooperatively inhibit NSCLC tumor growth in vivo to a greater extent than either monotherapy alone Journal of Thoracic Oncology. 11: S41. DOI: 10.1016/J.Jtho.2015.12.069 |
0.376 |
|
2010 |
Jung ME, Chaumontet M, Salehi-Rad R. Total synthesis of auripyrone B using a non-aldol aldol-cuprate opening process. Organic Letters. 12: 2872-5. PMID 20499854 DOI: 10.1021/Ol100985N |
0.417 |
|
2010 |
Jung ME, Salehi-Rad R. Dipyrone approach toward the synthesis of the cytotoxic natural product auripyrone A Tetrahedron Letters. 51: 4931-4933. DOI: 10.1016/J.Tetlet.2010.07.034 |
0.406 |
|
2009 |
Jung ME, Salehi-Rad R. Total synthesis of auripyrone A using a tandem non-aldol aldol/Paterson aldol process as a key step. Angewandte Chemie (International Ed. in English). 48: 8766-9. PMID 19824033 DOI: 10.1002/Anie.200904607 |
0.398 |
|
Show low-probability matches. |